Q1 2024 · 13F-HR
Newtyn Management, LLCholdings as filed
Filed 2024-05-15 · accession 0001493152-24-019810
$502.0M
Reported value
40
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 44891N208 | IAC | IAC INC | $75.9M | 15.1% | 1,423,000 | Common | SOLE |
| 698884103 | PAR | PAR TECHNOLOGY CORP | $56.6M | 11.3% | 1,246,885 | Common | SOLE |
| 13765N107 | CNNE | CANNAE HLDGS INC | $47.0M | 9.37% | 2,115,000 | Common | SOLE |
| 11040G103 | VTOL | BRISTOW GROUP INC | $29.2M | 5.82% | 1,074,000 | Common | SOLE |
| 590328209 | MACKEUR | MERRIMACK PHARMACEUTICALS IN | $27.7M | 5.51% | 1,873,694 | Common | SOLE |
| 03748R747 | AIV | APARTMENT INVT & MGMT CO | $24.6M | 4.89% | 3,000,000 | Common | SOLE |
| 19239V302 | CCOI | COGENT COMMUNICATIONS HLDGS | $24.5M | 4.88% | 375,000 | Common | SOLE |
| 84790A105 | SPB | SPECTRUM BRANDS HLDGS INC NE | $22.2M | 4.43% | 249,937 | Common | SOLE |
| 178587101 | CIO | CITY OFFICE REIT INC | $20.0M | 3.98% | 3,838,000 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $18.5M | 3.68% | 1,271,473 | Common | SOLE |
| 606710200 | MITK | MITEK SYS INC | $16.3M | 3.25% | 1,158,563 | Common | SOLE |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $14.7M | 2.94% | 1,643,930 | Common | SOLE |
| 55262C100 | MBI | MBIA INC | $12.7M | 2.52% | 1,875,000 | Common | SOLE |
| 18482P103 | CLFD | CLEARFIELD INC | $12.3M | 2.46% | 400,000 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $11.8M | 2.35% | 366,000 | Common | SOLE |
| 05368M106 | PPHMEUR | AVID BIOSERVICES INC | $10.1M | 2.00% | 1,500,000 | Common | SOLE |
| 65342T106 | NODK | NI HLDGS INC | $9.2M | 1.83% | 605,108 | Common | SOLE |
| 05603E208 | BVFL | BV FINL INC | $9.0M | 1.79% | 871,445 | Common | SOLE |
| 85512G106 | STHO | STAR HLDGS | $6.2M | 1.23% | 477,472 | Common | SOLE |
| 34984VAC4 | — | FORUM ENERGY TECHNOLOGIES IN | $5.5M | 1.09% | 5,483,872 | Common | SOLE |
| 315948109 | FBTC | FIDELITY WISE ORIGIN BITCOIN | $5.4M | 1.08% | 87,000 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $5.3M | 1.05% | 1,000,000 | Common | SOLE |
| 015658107 | ASTL | ALGOMA STL GROUP INC | $5.0M | 1.00% | 590,899 | Common | SOLE |
| 69331C108 | PCG | PG&E CORP | $4.5M | 0.90% | 268,921 | Common | SOLE |
| 34984V209 | FET | FORUM ENERGY TECHNOLOGIES IN | $3.9M | 0.77% | 194,300 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $3.1M | 0.61% | 500,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $2.9M | 0.58% | 250,000 | Common | SOLE |
| G63365103 | MURA | MURAL ONCOLOGY PUB LTD CO | $2.4M | 0.49% | 500,000 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $2.4M | 0.47% | 1,700,000 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $2.0M | 0.40% | 623,690 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $1.8M | 0.35% | 165,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.7M | 0.34% | 150,000 | Common | SOLE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $1.6M | 0.32% | 400,000 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $1.4M | 0.29% | 1,118,892 | Common | SOLE |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $1.3M | 0.25% | 311,000 | Common | SOLE |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $1.2M | 0.23% | 1,200,000 | Common | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $976,741 | 0.19% | 930,230 | Common | SOLE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $653,112 | 0.13% | 46,189 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $633,750 | 0.13% | 125,000 | Common | SOLE |
| 52178J113 | LFLYW | LEAFLY HOLDINGS INC | $19,039 | 0.00% | 634,640 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.